Very first US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells ( – CAR-T – ) Modified to Reduce Immunogenicity is Awarded to Celyad, Business Wire

Very first US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells (“CAR-T”) Modified to Reduce Immunogenicity is Awarded to Celyad …